Vildagliptin


Indications and Reactions:

Role Indications Reactions
Secondary
Type 2 Diabetes Mellitus 29.7%
Diabetes Mellitus 20.0%
Product Used For Unknown Indication 10.3%
Hypertension 6.3%
Drug Use For Unknown Indication 4.0%
Hyperlipidaemia 2.9%
Lung Adenocarcinoma Metastatic 2.9%
Rheumatoid Arthritis 2.9%
Skin Ulcer 2.9%
Angina Pectoris 2.3%
Cardiac Failure 2.3%
Cerebral Infarction 2.3%
Constipation 2.3%
Diabetes Mellitus Inadequate Control 1.7%
Fungal Skin Infection 1.7%
Delirium 1.1%
Dementia 1.1%
Depression 1.1%
Diabetic Macular Oedema 1.1%
Gastritis 1.1%
Pemphigoid 26.0%
Liver Function Test Abnormal 10.0%
Respiratory Failure 8.0%
Swelling Face 8.0%
Hypoglycaemia 6.0%
Vomiting 6.0%
Generalised Erythema 4.0%
Lip Swelling 4.0%
Pancreatitis Acute 4.0%
Swollen Tongue 4.0%
Blood Pressure Diastolic Decreased 2.0%
C-reactive Protein Increased 2.0%
Enterocolitis 2.0%
Glycosylated Haemoglobin Increased 2.0%
Hepatic Function Abnormal 2.0%
Hepatocellular Injury 2.0%
Hyperglycaemia 2.0%
Interstitial Lung Disease 2.0%
Pulmonary Hypertension 2.0%
Pyrexia 2.0%
Concomitant
Product Used For Unknown Indication 22.5%
Hypertension 18.1%
Diabetes Mellitus 16.8%
Type 2 Diabetes Mellitus 13.8%
Obesity 3.5%
Nephrogenic Anaemia 3.1%
Rheumatoid Arthritis 2.8%
Cardiovascular Event Prophylaxis 1.9%
Hypothyroidism 1.9%
Constipation 1.8%
Diuretic Therapy 1.6%
Hypercholesterolaemia 1.6%
Blood Cholesterol Abnormal 1.5%
Hepatitis C 1.5%
Hyperglycaemia 1.5%
Infection Parasitic 1.3%
Prophylaxis 1.3%
Analgesic Therapy 1.2%
Castleman's Disease 1.2%
Hiv Infection 1.2%
Suicide Attempt 11.0%
Vomiting 11.0%
Death 8.2%
Hypoglycaemia 8.2%
Hyperkalaemia 6.8%
Renal Impairment 6.8%
Hyperglycaemia 5.5%
Myalgia 5.5%
Rash 4.1%
Renal Failure 4.1%
Urinary Tract Infection 4.1%
Anaemia 2.7%
Bladder Transitional Cell Carcinoma 2.7%
Blood Creatine Phosphokinase Increased 2.7%
Cardiac Failure 2.7%
Cheilitis 2.7%
Diabetes Mellitus Inadequate Control 2.7%
Gastrointestinal Haemorrhage 2.7%
Hepatic Function Abnormal 2.7%
Hypertensive Crisis 2.7%

Drug Data